Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Nanoscale Horizons
|
March 23, 2023
Simple engineering of hybrid cellulose nanocrystal-gold nanoparticles results in a functional glyconanomaterial with biomolecular recognition properties
Giacomo Biagiotti, Gianluca Toniolo, Martin Albino, et al.
Oncoimmunology
|
February 5, 2019
Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Hector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, et al.
Cancers
|
May 28, 2022
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors
Hector Terán-Navarro, Andrea Zeoli, David Salines-Cuevas, et al.
Biomacromolecules
|
September 9, 2016
Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo
Ana B Benito, Miren K Aiertza, Marco Marradi, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats
Hessel van der Weide, Unai Cossío, Raquel Gracia, et al.
Oncotarget
|
September 15, 2017
GNP-GAPDH<sub>1-22</sub> nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination
Ricardo Calderon-Gonzalez, Elisabet Frande-Cabanes, Hector Teran-Navarro, et al.
The FEBS Journal
|
May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancer
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal
|
March 22, 2021
Emerging glyco-based strategies to steer immune responses
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
Chemical Society Reviews
|
December 21, 2012
Multivalent glycoconjugates as anti-pathogenic agents
Anna Bernardi, Jesus Jiménez-Barbero, Alessandro Casnati, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Nanoscale Horizons
|
March 23, 2023
Simple engineering of hybrid cellulose nanocrystal-gold nanoparticles results in a functional glyconanomaterial with biomolecular recognition properties
Giacomo Biagiotti, Gianluca Toniolo, Martin Albino, et al.
Oncoimmunology
|
February 5, 2019
Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Hector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, et al.
Cancers
|
May 28, 2022
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors
Hector Terán-Navarro, Andrea Zeoli, David Salines-Cuevas, et al.
Biomacromolecules
|
September 9, 2016
Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo
Ana B Benito, Miren K Aiertza, Marco Marradi, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats
Hessel van der Weide, Unai Cossío, Raquel Gracia, et al.
Oncotarget
|
September 15, 2017
GNP-GAPDH<sub>1-22</sub> nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination
Ricardo Calderon-Gonzalez, Elisabet Frande-Cabanes, Hector Teran-Navarro, et al.
The FEBS Journal
|
May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancer
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal
|
March 22, 2021
Emerging glyco-based strategies to steer immune responses
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
Chemical Society Reviews
|
December 21, 2012
Multivalent glycoconjugates as anti-pathogenic agents
Anna Bernardi, Jesus Jiménez-Barbero, Alessandro Casnati, et al.
Page
of 6